The thesis
SilentDip rests on a clean, well-grounded idea: a sharp price drop without a negative headline tends to be a noise-driven overreaction that reverts, while the same drop carrying genuine bad news keeps drifting lower. The strategy therefore demands two things at once — oversold technicals (a stretched RSI, a price well below SMA20) and the absence of salient negative sentiment — before it buys. It exits as names mean-revert back toward SMA20 or as RSI normalizes.
The approach is explicitly literature-backed, extending Chan's 2003 work on price reactions to news versus no-news (Clinch, He, Landsman & Li, SSRN working paper, Nov 2025). That intellectual pedigree is a point in its favor: this is a documented anomaly, not a curve-fit pattern. The universe is a conservative 24-name roster of mega-cap, high-liquidity stocks (AAPL, MSFT, JPM, JNJ, XOM and peers), which keeps execution clean and avoids the micro-cap traps where "no news" often just means "no coverage."
Backtest and validation
The headline numbers are attractive. Over 1,279 trading days the strategy returned 52.62% (8.69% CAGR), with a Sharpe of 1.03, a contained 10.38% max drawdown, and a high 70.55% win rate across 294 trades. Fees were negligible ($294 total) and FX cost was zero.
More importantly, the validation holds up where many strategies fall apart. All four walk-forward folds were positive, the out-of-sample return was 16.75% at a 1.91 Sharpe, and the Probabilistic Sharpe Ratio sits at 0.991 — strong evidence the edge isn't a fluke of a single regime.
The risks worth naming
Balance demands scrutiny of the soft spots. First, the Deflated Sharpe Ratio is only 0.563. After accounting for 42 trials of selection, the probability the true Sharpe clears the bar is a coin-flip-plus — materially less reassuring than the raw PSR suggests, and the single most important caveat here.
Second, the returns are front-loaded in time, not evenly earned. Folds 1 and 2 (late 2021 through early 2024) returned just 4.96% and 1.91% at Sharpes near 0.35, while folds 3 and 4 produced 26.26% and 16.75% at Sharpes above 1.8. Most of the performance came from the recent, friendlier tape. Third, turnover is a hefty 4,192% — benign at these flat fees, but a reminder the edge depends on frequent re-entry.
Live activity
The live book is young and, fittingly, quiet. Since going live around Oct 13 the strategy has mostly stood pat — most scheduled runs executed nothing, which is by design: it waits for the specific oversold-plus-no-news setup. Its one trade was a 29-share BAC buy at $51 on Oct 14. Portfolio value has drifted in a narrow band and currently reads $9,979 against the $10,000 start — essentially flat, slightly negative.
Bottom line
SilentDip is one of the better-validated strategies in the stable, with a real academic thesis and robust walk-forward evidence. Temper that against a modest DSR and gains concentrated in recent, favorable conditions. The quiet live start is not a red flag — it's the strategy doing exactly what it promises. Judge it on how it behaves in the next genuine, headline-free selloff.